| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |